320 related articles for article (PubMed ID: 24382972)
1. Interleukin-17: a promoter in colorectal cancer progression.
Wu D; Wu P; Huang Q; Liu Y; Ye J; Huang J
Clin Dev Immunol; 2013; 2013():436307. PubMed ID: 24382972
[TBL] [Abstract][Full Text] [Related]
2. Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer.
Dmitrieva-Posocco O; Dzutsev A; Posocco DF; Hou V; Yuan W; Thovarai V; Mufazalov IA; Gunzer M; Shilovskiy IP; Khaitov MR; Trinchieri G; Waisman A; Grivennikov SI
Immunity; 2019 Jan; 50(1):166-180.e7. PubMed ID: 30650375
[TBL] [Abstract][Full Text] [Related]
3. IL-17 and colorectal cancer: From carcinogenesis to treatment.
Razi S; Baradaran Noveiry B; Keshavarz-Fathi M; Rezaei N
Cytokine; 2019 Apr; 116():7-12. PubMed ID: 30684916
[TBL] [Abstract][Full Text] [Related]
4. Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma.
Chai BY; Yip WK; Dusa N; Mohtarrudin N; Seow HF
Pathol Oncol Res; 2020 Oct; 26(4):2291-2298. PubMed ID: 32462420
[TBL] [Abstract][Full Text] [Related]
5. The IL-23 to IL-17 cascade inflammation-related cancers.
Wang K; Karin M
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S87-90. PubMed ID: 26457610
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of IL-17 in colorectal inflammation-cancer transition].
Li C; He S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Feb; 38(2):177-182. PubMed ID: 35356887
[TBL] [Abstract][Full Text] [Related]
7. The role of interleukin-17A in colorectal tumorigenesis.
Shi Y; Lin H; Cui J; Qi H; Florholmen J; Liu Z; Cui G
Cancer Biother Radiopharm; 2013; 28(6):429-32. PubMed ID: 23701420
[TBL] [Abstract][Full Text] [Related]
8. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
Grivennikov SI; Wang K; Mucida D; Stewart CA; Schnabl B; Jauch D; Taniguchi K; Yu GY; Osterreicher CH; Hung KE; Datz C; Feng Y; Fearon ER; Oukka M; Tessarollo L; Coppola V; Yarovinsky F; Cheroutre H; Eckmann L; Trinchieri G; Karin M
Nature; 2012 Nov; 491(7423):254-8. PubMed ID: 23034650
[TBL] [Abstract][Full Text] [Related]
9. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
[TBL] [Abstract][Full Text] [Related]
10. Dynamic stromal cellular reaction throughout human colorectal adenoma-carcinoma sequence: A role of TH17/IL-17A.
Cui G; Li Z; Florholmen J; Goll R
Biomed Pharmacother; 2021 Aug; 140():111761. PubMed ID: 34044278
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer.
Chang PH; Pan YP; Fan CW; Tseng WK; Huang JS; Wu TH; Chou WC; Wang CH; Yeh KY
Cancer Med; 2016 Mar; 5(3):426-33. PubMed ID: 26799163
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 level in patients with colorectal cancer.
Li YX; Zhang L; Simayi D; Zhang N; Tao L; Yang L; Zhao J; Chen YZ; Li F; Zhang WJ
PLoS One; 2015; 10(2):e0118391. PubMed ID: 25706309
[TBL] [Abstract][Full Text] [Related]
13. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
Front Immunol; 2020; 11():980. PubMed ID: 32670264
[TBL] [Abstract][Full Text] [Related]
15. Intestinal inflammation and colorectal cancer: a double-edged sword?
Rizzo A; Pallone F; Monteleone G; Fantini MC
World J Gastroenterol; 2011 Jul; 17(26):3092-100. PubMed ID: 21912451
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
[TBL] [Abstract][Full Text] [Related]
17. Immune cells: plastic players along colorectal cancer progression.
Di Caro G; Marchesi F; Laghi L; Grizzi F
J Cell Mol Med; 2013 Sep; 17(9):1088-95. PubMed ID: 24151976
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6--a key regulator of colorectal cancer development.
Waldner MJ; Foersch S; Neurath MF
Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-17 in human colorectal cancer.
Wägsäter D; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2006; 26(6B):4213-6. PubMed ID: 17201135
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis.
Jou E; Rodriguez-Rodriguez N; McKenzie ANJ
Front Immunol; 2022; 13():981479. PubMed ID: 36263033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
